Eastleigh, United Kingdom

Jeremy Kilburn

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Theryte Limited. Active years: 2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jeremy Kilburn. Retrieved from https://idiyas.com/inventor/jeremy-kilburn

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0


Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2014

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Jeremy Kilburn

Introduction

Jeremy Kilburn, an accomplished inventor based in Eastleigh, GB, has made significant strides in the field of medical research with his innovative approach to cancer treatment. With one patent to his name, Kilburn is dedicated to enhancing the efficacy of cancer therapies through novel peptide applications.

Latest Patents

Jeremy Kilburn holds a noteworthy patent focused on treating cancer. His invention comprises a peptide featuring an amino acid sequence that is either a part of the CDK4 protein or homologous to it. This peptide demonstrates cytotoxic properties against cancer cells, exhibits an ability to inhibit cancer cell growth, and can stimulate the growth of non-cancerous or control cells. Kilburn's patent also describes methods for identifying such peptides along with their medical applications, promising potential advancements in cancer therapy.

Career Highlights

Kilburn's career is marked by his role at Theryte Limited, where he employs his expertise in the development of innovative cancer treatments. His work is rooted in cutting-edge research that seeks to offer better solutions for patients battling cancer. He is committed to researching and developing peptide-based therapies that could lead to significant improvements in treatment outcomes.

Collaborations

Throughout his journey, Jeremy Kilburn has collaborated with several talented individuals in the field. Notably, he has worked alongside Hilmar Meek Warenius and Jonathan Essex, forming strong professional partnerships aimed at advancing medical research and innovating in the cancer treatment landscape.

Conclusion

In summary, Jeremy Kilburn exemplifies the spirit of innovation in the medical field, particularly in cancer treatment. His patent highlights the potential of peptide therapies, showcasing his commitment to improving healthcare outcomes. As he continues to collaborate and contribute to the research community, Kilburn's work is poised to make a lasting impact on cancer treatments and inspire future innovations.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…